glp1 drug data

Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings to offset any impact from impending restrictions on selling copies of Novo Nordisk's obesity drug. Shares of Hims & Hers closed 5.1% higher after the company said it will expand its weight-loss offerings with branded versions of Lilly's tirzepatide — the active ingredient in weight-loss drug Zepbound and diabetes medicine Mounjaro — and generics of Novo's diabetes drug, liraglutide.

Hims to Sell Lilly’s Zepbound Through Telehealth Platform

Hims & Hers Health Inc.’s shares rose Tuesday after it said it was broadening its weight-loss offerings, adding access to ...

Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform

Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co. Zepbound and generic ...

Hims & Hers shares rise as company adds Eli Lilly's Zepbound

CNBC's Brandon Gomez joins 'Closing Bell' to discuss Hims & Hers shares rising as company adds new weight-loss medications to ...

Hims & Hers Zepbound Offering Won’t Bring Needed Sales Boom, Analysts Say

Investors worry patients won’t make that price leap and that Hims, which has built its business on affordable healthcare, ...

Hims & Hers shares rise as company adds new weight-loss medications to platform

Hims & Hers Health shares rose more than 5% on Tuesday after the company announced patients can access Eli Lilly's weight loss medication Zepbound and diabetes drug Mounjaro, as well as the ...

Hims & Hers to sell Lilly's Zepbound on its telehealth platform

(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on ...

Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform. The treatments will each cost $ ...

‘Don’t Fall for the Hype,’ Says Top Analyst about HIMS’ Decision to Sell Zepbound

Shares of Hims & Hers Health (HIMS) rallied on Tuesday after the telehealth company said it would begin selling branded versions of Eli Lill...

Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...

Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform

Hims & Hers to shut down dermatology business Apostrophe

March 7 (Reuters) - Hims & Hers Health (HIMS.N), opens new ... the active ingredient in its top-selling medicines Wegovy and Ozempic, was removed from the U.S. health regulator's shortage list ...

Hims & Hers shares rise as company adds new weight-loss medications to platform

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...

Hims Is Begging Customers to Lobby the FDA to Keep Its Ozempic Knockoffs Legal

Hims currently offers compounded semaglutide at a price of $165 a month — compared to $1,799 a month for Ozempic, and a whopping $1,999 for Wegovy. Others argue that US taxpayers have already ...

Why Hims & Hers Health Stock Soared Tuesday

Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up by as much as 14% earlier. The day's gain was powered by the telehealth company's ...

Will FDA deadlines reduce compounded versions of Ozempic?

With a FDA deadline set for March 26 to stop compounding versions of Zepbound ... March 19. Hims & Hers Health has said it will keep providing compounded versions of Ozempic and Wegovy tailored ...

The Ozempic era is only just beginning

In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions left to answer, not least what the future holds for weight-loss medications and society at large

Thank God I’ve stopped microdosing Ozempic – this is what it’s really like

Recent figures suggest more than half a million people in the UK are taking Mounjaro or Wegovy (the version of Ozempic approved for weight loss, rather than diabetes control, although private ...

How Much Should Weight Loss Drugs Cost?

But doctors say it’s difficult to go cold turkey. How to Choose: As patients consider drugs like Wegovy, Ozempic, Zepbound and Mounjaro to treat obesity, experts say the choices are not so simple.

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies. Shares of Hims & Hers Health, which advertised its compounded versions of weight-loss drugs during the Super Bowl this month, plunged 22% to $52, on a day it announced the purchase of a plant to make the class of drugs that includes Wegovy and Ozempic. U.S. regulations allow compounding pharmacies to copy brand-name medicines that are in short supply.